INTRODUCTION: Some clinical features have been associated with the progression and remission of alopecia areata (AA). We aim to determine possible prognostic factors in Mexican patients with AA. METHODS: This prospective study of a 1-year follow-up included Mexican patients with a clinical diagnosis of AA. We evaluated disease activity with the SALT score at the first visit and 1-year follow-up; progression, no progression, and remission were defined according to score changes. We used multiple linear regression model to detect factors associated with progression and remission. RESULTS: One hundred and four patients concluded the study. Ninety-seven patients (93.3%) had patchy AA. Fifteen patients showed disease progression and 89 no progression, of which 35 patients had remission. Body hair involvement was related to disease progression and adherence to treatment with disease remission and progression. CONCLUSIONS: Body hair involvement is related to poor prognosis. Adherence to treatment is a modifiable prognostic factor associated with the course of AA in Mexican patients.
INTRODUCTION: Some clinical features have been associated with the progression and remission of alopecia areata (AA). We aim to determine possible prognostic factors in Mexican patients with AA. METHODS: This prospective study of a 1-year follow-up included Mexican patients with a clinical diagnosis of AA. We evaluated disease activity with the SALT score at the first visit and 1-year follow-up; progression, no progression, and remission were defined according to score changes. We used multiple linear regression model to detect factors associated with progression and remission. RESULTS: One hundred and four patients concluded the study. Ninety-seven patients (93.3%) had patchy AA. Fifteen patients showed disease progression and 89 no progression, of which 35 patients had remission. Body hair involvement was related to disease progression and adherence to treatment with disease remission and progression. CONCLUSIONS: Body hair involvement is related to poor prognosis. Adherence to treatment is a modifiable prognostic factor associated with the course of AA in Mexican patients.
Authors: Elise A Olsen; Maria K Hordinsky; Vera H Price; Janet L Roberts; Jerry Shapiro; Doug Canfield; Madeleine Duvic; Lloyd E King; Amy J McMichael; Valerie A Randall; Maria L Turner; Leonard Sperling; David A Whiting; David Norris Journal: J Am Acad Dermatol Date: 2004-09 Impact factor: 11.527
Authors: Yong Hyun Jang; Nam-Soo Hong; Sun Young Moon; Dong Hyuk Eun; Won Kee Lee; Seong Geun Chi; Jun Young Kim; Weon Ju Lee; Seok-Jong Lee; Do Won Kim Journal: Dermatology Date: 2017-07-14 Impact factor: 5.366
Authors: Carlo Selmi; Patrick S C Leung; David H Sherr; Marilyn Diaz; Jennifer F Nyland; Marc Monestier; Noel R Rose; M Eric Gershwin Journal: J Autoimmun Date: 2012-06-28 Impact factor: 7.094
Authors: S Vañó-Galván; P Fernández-Crehuet; R Grimalt; M J Garcia-Hernandez; R Rodrigues-Barata; S Arias-Santiago; A Molina-Ruiz; E Garcia-Lora; J Dominguez-Cruz; A Brugues; J Ferrando; C Serrano-Falcón; S Serrano; J Paoli; F Camacho Journal: J Eur Acad Dermatol Venereol Date: 2016-10-06 Impact factor: 6.166
Authors: C Herbert Pratt; Lloyd E King; Andrew G Messenger; Angela M Christiano; John P Sundberg Journal: Nat Rev Dis Primers Date: 2017-03-16 Impact factor: 52.329
Authors: Marie T Brown; Jennifer Bussell; Suparna Dutta; Katherine Davis; Shelby Strong; Suja Mathew Journal: Am J Med Sci Date: 2016-04 Impact factor: 2.378